Table I.
Association between miR-138 expression and the clinicopathological features of human cervical cancer.
| Feature | No. of patients | Relative miR-138 level | P-value |
|---|---|---|---|
| Age, years | 0.743 | ||
| <55 | 16 | 0.42±0.11 | |
| ≥55 | 20 | 0.42±0.09 | |
| Tumor size | 0.718 | ||
| <5 cm | 19 | 0.41±0.10 | |
| ≥5 cm | 17 | 0.43±0.08 | |
| Histological grades | 0.152 | ||
| Well/moderate | 24 | 0.44±0.12 | |
| Poor | 12 | 0.38±0.09 | |
| FIGO stage | <0.010 | ||
| Ib-IIa | 22 | 0.53±0.11 | |
| IIb-IIIa | 14 | 0.25±0.06 | |
| Lymph node metastasis | <0.010 | ||
| No | 28 | 0.48±0.08 | |
| Yes | 8 | 0.21±0.06 |
miR-138, microRNA-138; FIGO, International Federation of Gynecology and Obstetrics.